Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development) - Image 1

£80.09

Humana Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Name: Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
Brand: Humana
Price: 80.09 GBP
Availability: InStock

Oncology

About as cheap as it gets. The only time it was cheaper was 9 months ago.

£80 today · all-time low £80 (Aug 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 212 days • 212 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 212 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £80 (194 days, 91.5%)

Price range: £80 - £108

Price levels: 2 different prices over 212 days

Description

Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future treatments in cancer therapy. Review "It offers everyone in the field of cancer drug development and therapy a powerful new understanding of the optimal sequencing and scheduling of new combination drug therapies necessary to maximize the effects of cancer patients." - Neoplasma From the Back Cover Early clinical trials of the new molecular-based anticancer agents have shown that many are marginal in controlling cancer, but prove to be potent modulators and potentiators of chemotherapy-induced apoptosis when used in combination with classic cytotoxic drugs or radiation. In Combination Cancer Therapy: Modulators and Potentiators, expert physician-scientists and clinicians with first-hand experience in the clinical development of targeted therapies review those combinations that hold the most promise for the future of medical oncology, detailing their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory benchtop to the patient's bedside as a new generation of cancer therapeutics. Cutting-edge and forward-looking, Combination Cancer Therapy: Modulators and Potentiators offers everyone in the fields of cancer drug development and therapy a powerful new understanding of the optimal sequencing and scheduling of new combination drug therapies necessary to maximize the effects for cancer patients today.

Product Specifications

Brand: Humana
Format: Paperback
ASIN: 162703806X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 25 November 2014
Listed Since: 27 November 2014

Barcode

No barcode data available

Humana Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

About as cheap as it gets. The only time it was cheaper was 9 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

Cancer Chemotherapy 1: Cancer Treatment and Research: 7

Cancer Chemotherapy: Basic Science to the Clinic

Springer Cancer Chemotherapy Volume 36 - Research Series

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Cancer Cell Chemoresistance And Chemosensitization

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

Wiley-Blackwell Cancer Consult: Expertise for Clinical Practice

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Academic Press pH-Interfering Agents in Cancer Therapy Vol 10

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Oxford Textbook of Cancer Biology (Oxford Textbooks in Oncology)

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Advances in Cancer Research: 77: Volume 77

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)

UICC Manual of Clinical Oncology